Tuesday, June 8, 2021

Glenmark Says Interim Data from Study Supports Favipiravir's Safety, Effectiveness in Covid Treatment

The study commenced in July 2020, aimed to evaluate safety and efficacy of favipiravir in mild to moderate COVID-19 patients.

from Top World News- News18.com https://ift.tt/3g0M3jt

No comments:

Post a Comment